INBX logo

Inhibrx Biosciences, Inc. (INBX) Operating Profit

Annual Operating Profit:

-$331.45M-$178.70M(-116.99%)
December 31, 2024

Summary

  • As of today, INBX annual operating income is -$331.45 million, with the most recent change of -$178.70 million (-116.99%) on December 31, 2024.
  • During the last 3 years, INBX annual operating profit has fallen by -$254.88 million (-332.90%).
  • INBX annual operating profit is now -1580.09% below its all-time high of -$19.73 million, reached on December 31, 2017.

Performance

INBX Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINBXincome statement metrics

Quarterly Operating Profit:

-$33.81M-$6.42M(-23.45%)
September 30, 2025

Summary

  • As of today, INBX quarterly operating income is -$33.81 million, with the most recent change of -$6.42 million (-23.45%) on September 30, 2025.
  • Over the past year, INBX quarterly operating profit has increased by +$12.98 million (+27.75%).
  • INBX quarterly operating profit is now -836.10% below its all-time high of -$3.61 million, reached on March 31, 2019.

Performance

INBX Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINBXincome statement metrics

TTM Operating Profit:

-$154.03M+$12.98M(+7.77%)
September 30, 2025

Summary

  • As of today, INBX TTM operating income is -$154.03 million, with the most recent change of +$12.98 million (+7.77%) on September 30, 2025.
  • Over the past year, INBX TTM operating profit has increased by +$127.49 million (+45.29%).
  • INBX TTM operating profit is now -1631.26% below its all-time high of -$8.90 million, reached on March 31, 2018.

Performance

INBX TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINBXincome statement metrics

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

INBX Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-117.0%+27.8%+45.3%
3Y3 Years-332.9%-12.7%-36.3%
5Y5 Years-658.2%-117.3%-130.6%

INBX Operating Profit Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-332.9%at low-23.4%+79.0%-36.3%+53.5%
5Y5-Year-658.2%at low-117.3%+79.0%-130.6%+53.5%
All-TimeAll-Time-1580.1%at low-836.1%+79.0%-1631.3%+53.5%

INBX Operating Profit History

DateAnnualQuarterlyTTM
Sep 2025
-
-$33.81M(-23.5%)
-$154.03M(+7.8%)
Jun 2025
-
-$27.39M(+36.2%)
-$167.01M(+44.4%)
Mar 2025
-
-$42.90M(+14.1%)
-$300.52M(+9.3%)
Dec 2024
-$331.45M(-117.0%)
-$49.93M(-6.7%)
-$331.45M(-17.7%)
Sep 2024
-
-$46.80M(+70.9%)
-$281.52M(-19.9%)
Jun 2024
-
-$160.90M(-117.9%)
-$234.72M(-103.8%)
Mar 2024
-
-$73.83M(-78.6%)
-$115.16M(+23.5%)
Dec 2023
-$152.75M(-32.5%)
-
-
Jun 2023
-
-$41.34M(+5.5%)
-$150.61M(-4.7%)
Mar 2023
-
-$43.77M(-23.3%)
-$143.87M(-11.4%)
Dec 2022
-$115.32M(-50.6%)
-$35.50M(-18.3%)
-$129.12M(-14.2%)
Sep 2022
-
-$30.00M(+13.3%)
-$113.02M(-11.0%)
Jun 2022
-
-$34.60M(-19.2%)
-$101.82M(-17.0%)
Mar 2022
-
-$29.02M(-49.5%)
-$87.02M(-13.7%)
Dec 2021
-$76.56M
-$19.40M(-3.2%)
-$76.56M(-3.1%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$18.80M(+5.1%)
-$74.27M(-4.6%)
Jun 2021
-
-$19.80M(-6.7%)
-$71.02M(-3.9%)
Mar 2021
-
-$18.56M(-8.5%)
-$68.39M(-1.4%)
Dec 2020
-$67.44M(-54.3%)
-$17.11M(-10.0%)
-$67.44M(-1.0%)
Sep 2020
-
-$15.56M(+9.4%)
-$66.79M(-3.9%)
Jun 2020
-
-$17.17M(+2.5%)
-$64.28M(-11.4%)
Mar 2020
-
-$17.61M(-7.0%)
-$57.71M(-32.0%)
Dec 2019
-$43.71M(-48.1%)
-$16.45M(-26.1%)
-$43.71M(-60.4%)
Sep 2019
-
-$13.05M(-23.1%)
-$27.26M(-91.8%)
Jun 2019
-
-$10.60M(-193.5%)
-$14.21M(-38.2%)
Mar 2019
-
-$3.61M(+45.9%)
-$10.29M(+33.9%)
Dec 2018
-$29.51M(-49.6%)
-
-
Jun 2018
-
-$6.67M(+25.0%)
-$15.57M(-75.0%)
Mar 2018
-
-$8.90M
-$8.90M
Dec 2017
-$19.73M
-
-

FAQ

  • What is Inhibrx Biosciences, Inc. annual operating income?
  • What is the all-time high annual operating profit for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. annual operating profit year-on-year change?
  • What is Inhibrx Biosciences, Inc. quarterly operating income?
  • What is the all-time high quarterly operating profit for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. quarterly operating profit year-on-year change?
  • What is Inhibrx Biosciences, Inc. TTM operating income?
  • What is the all-time high TTM operating profit for Inhibrx Biosciences, Inc.?
  • What is Inhibrx Biosciences, Inc. TTM operating profit year-on-year change?

What is Inhibrx Biosciences, Inc. annual operating income?

The current annual operating profit of INBX is -$331.45M

What is the all-time high annual operating profit for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high annual operating income is -$19.73M

What is Inhibrx Biosciences, Inc. annual operating profit year-on-year change?

Over the past year, INBX annual operating income has changed by -$178.70M (-116.99%)

What is Inhibrx Biosciences, Inc. quarterly operating income?

The current quarterly operating profit of INBX is -$33.81M

What is the all-time high quarterly operating profit for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high quarterly operating income is -$3.61M

What is Inhibrx Biosciences, Inc. quarterly operating profit year-on-year change?

Over the past year, INBX quarterly operating income has changed by +$12.98M (+27.75%)

What is Inhibrx Biosciences, Inc. TTM operating income?

The current TTM operating profit of INBX is -$154.03M

What is the all-time high TTM operating profit for Inhibrx Biosciences, Inc.?

Inhibrx Biosciences, Inc. all-time high TTM operating income is -$8.90M

What is Inhibrx Biosciences, Inc. TTM operating profit year-on-year change?

Over the past year, INBX TTM operating income has changed by +$127.49M (+45.29%)
On this page